Intranasal mesenchymal stem cell therapy to boost myelination after encephalopathy of prematurity

Encephalopathy of prematurity (EoP) is a common cause of long‐term neurodevelopmental morbidity in extreme preterm infants. Diffuse white matter injury (dWMI) is currently the most commonly observed form of EoP. Impaired maturation of oligodendrocytes (OLs) is the main underlying pathophysiological mechanism. No therapies are currently available to combat dWMI. Intranasal application of mesenchymal stem cells (MSCs) is a promising therapeutic option to boost neuroregeneration after injury. Here, we developed a double‐hit dWMI mouse model and investigated the therapeutic potential of intranasal MSC therapy. Postnatal systemic inflammation and hypoxia‐ischemia led to transient deficits in cortical myelination and OL maturation, functional deficits and neuroinflammation. Intranasal MSCs migrated dispersedly into the injured brain and potently improved myelination and functional outcome, dampened cerebral inflammationand rescued OL maturation after dWMI. Cocultures of MSCs with primary microglia or OLs show that MSCs secrete factors that directly promote OL maturation and dampen neuroinflammation. We show that MSCs adapt their secretome after ex vivo exposure to dWMI milieu and identified several factors including IGF1, EGF, LIF, and IL11 that potently boost OL maturation. Additionally, we showed that MSC‐treated dWMI brains express different levels of these beneficial secreted factors. In conclusion, the combination of postnatal systemic inflammation and hypoxia‐ischemia leads to a pattern of developmental brain abnormalities that mimics the clinical situation. Intranasal delivery of MSCs, that secrete several beneficial factors in situ, is a promising strategy to restore myelination after dWMI and subsequently improve the neurodevelopmental outcome of extreme preterm infants in the future.

[1]  Resident,et al.  Resident , 2020, The Caravan.

[2]  M. C. Angulo,et al.  The cerebral cortex is a substrate of multiple interactions between GABAergic interneurons and oligodendrocyte lineage cells , 2019, Neuroscience Letters.

[3]  M. Benders,et al.  The Potential of Stem Cell Therapy to Repair White Matter Injury in Preterm Infants: Lessons Learned From Experimental Models , 2019, Front. Physiol..

[4]  S. Allan,et al.  The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke , 2018, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  A. Gunn,et al.  Chronic inflammation and impaired development of the preterm brain. , 2018, Journal of reproductive immunology.

[6]  P. Calabresi,et al.  Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone‐induced demyelination , 2017, Glia.

[7]  R. Dijkhuizen,et al.  A quantitative method for microstructural analysis of myelinated axons in the injured rodent brain , 2017, Scientific Reports.

[8]  Neil Marlow,et al.  Cognitive trajectories from infancy to early adulthood following birth before 26 weeks of gestation: a prospective, population-based cohort study , 2017, Archives of Disease in Childhood.

[9]  D. Rowitch,et al.  Origin and dynamics of oligodendrocytes in the developing brain: Implications for perinatal white matter injury , 2017, Glia.

[10]  Annette van der Toorn,et al.  Combined fetal inflammation and postnatal hypoxia causes myelin deficits and autism‐like behavior in a rat model of diffuse white matter injury , 2017, Glia.

[11]  Y. A. Lee.  White Matter Injury of Prematurity: Its Mechanisms and Clinical Features , 2017, Journal of pathology and translational medicine.

[12]  J. Volpe.  Confusions in Nomenclature: "Periventricular Leukomalacia" and "White Matter Injury"-Identical, Distinct, or Overlapping? , 2017, Pediatric neurology.

[13]  D. Offen,et al.  Concise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases , 2017, Stem cells.

[14]  Elena Tremoli,et al.  The role of oligodendrocyte precursor cells expressing the GPR17 receptor in brain remodeling after stroke , 2017, Cell Death & Disease.

[15]  S. Back.  White matter injury in the preterm infant: pathology and mechanisms , 2017, Acta Neuropathologica.

[16]  B. Allison,et al.  Perinatal Brain Injury As a Consequence of Preterm Birth and Intrauterine Inflammation: Designing Targeted Stem Cell Therapies , 2017, Front. Neurosci..

[17]  B. Kramer,et al.  Wharton's Jelly Mesenchymal Stem Cells Protect the Immature Brain in Rats and Modulate Cell Fate. , 2017, Stem cells and development.

[18]  Martin Mueller,et al.  Intranasal Delivery of Umbilical Cord-Derived Mesenchymal Stem Cells Preserves Myelination in Perinatal Brain Damage. , 2016, Stem cells and development.

[19]  Hye Soo Yoo,et al.  Optimal Timing of Mesenchymal Stem Cell Therapy for Neonatal Intraventricular Hemorrhage , 2016, Cell transplantation.

[20]  Petronella Anbeek,et al.  Brain Volumes at Term-Equivalent Age in Preterm Infants: Imaging Biomarkers for Neurodevelopmental Outcome through Early School Age. , 2016, The Journal of pediatrics.

[21]  M. Cimino,et al.  GPR17 expressing NG2‐Glia: Oligodendrocyte progenitors serving as a reserve pool after injury , 2016, Glia.

[22]  M. Benders,et al.  Impaired oligodendrocyte maturation in preterm infants: Potential therapeutic targets , 2016, Progress in Neurobiology.

[23]  B. Poindexter,et al.  Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. , 2015, JAMA.

[24]  Prakhar Mishra,et al.  The overwhelming use of rat models in nerve regeneration research may compromise designs of nerve guidance conduits for humans , 2015, Journal of Materials Science: Materials in Medicine.

[25]  A. de Bruin,et al.  Assessment of long-term safety and efficacy of intranasal mesenchymal stem cell treatment for neonatal brain injury in the mouse , 2015, Pediatric Research.

[26]  K. Blomgren,et al.  Resident microglia, rather than blood‐derived macrophages, contribute to the earlier and more pronounced inflammatory reaction in the immature compared with the adult hippocampus after hypoxia‐ischemia , 2015, Glia.

[27]  B. Khakh,et al.  Diversity of astrocyte functions and phenotypes in neural circuits , 2015, Nature Neuroscience.

[28]  V. Gallo,et al.  GABAergic regulation of cerebellar NG2-cell development is altered in perinatal white matter injury , 2015, Nature Neuroscience.

[29]  S. Fumagalli,et al.  Shape descriptors of the “never resting” microglia in three different acute brain injury models in mice , 2015, Intensive Care Medicine Experimental.

[30]  A. Kavelaars,et al.  Intranasal Administration of Human MSC for Ischemic Brain Injury in the Mouse: In Vitro and In Vivo Neuroregenerative Functions , 2014, PloS one.

[31]  R. Dijkhuizen,et al.  Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury , 2014, Experimental Neurology.

[32]  T. Kilpatrick,et al.  Adult Neural Precursor Cells from the Subventricular Zone Contribute Significantly to Oligodendrocyte Regeneration and Remyelination , 2014, The Journal of Neuroscience.

[33]  H. Tse,et al.  Paracrine Mechanisms of Mesenchymal Stem Cell-Based Therapy: Current Status and Perspectives , 2014, Cell transplantation.

[34]  N. Downes,et al.  The Development of Myelin in the Brain of the Juvenile Rat , 2014, Toxicologic pathology.

[35]  Steven P. Miller,et al.  Brain injury in premature neonates: A primary cerebral dysmaturation disorder? , 2014, Annals of neurology.

[36]  Q. Zhuge,et al.  Timing and Dose Regimens of Marrow Mesenchymal Stem Cell Transplantation Affect the Outcomes and Neuroinflammatory Response After Ischemic Stroke , 2014, CNS neuroscience & therapeutics.

[37]  T. Pozzan,et al.  Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process , 2014, Cell Death and Differentiation.

[38]  F. Vaccarino,et al.  Neurobiology of premature brain injury , 2014, Nature Neuroscience.

[39]  F. Hyder,et al.  Intranasal epidermal growth factor treatment rescues neonatal brain injury , 2013, Nature.

[40]  S. V. Anisimov,et al.  The secretome of mesenchymal stem cells: potential implications for neuroregeneration. , 2013, Biochimie.

[41]  Yuxia Xu,et al.  Effect of intrauterine infection on brain development and injury , 2013, International Journal of Developmental Neuroscience.

[42]  Peter Andriessen,et al.  Mesenchymal Stem Cells Induce T-Cell Tolerance and Protect the Preterm Brain after Global Hypoxia-Ischemia , 2013, PloS one.

[43]  K. Blomgren,et al.  Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species , 2013, Progress in Neurobiology.

[44]  M. Fukaya,et al.  Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain , 2013, Nature Neuroscience.

[45]  M. Kas,et al.  Intranasal Mesenchymal Stem Cell Treatment for Neonatal Brain Damage: Long-Term Cognitive and Sensorimotor Improvement , 2013, PloS one.

[46]  Manuel Graña,et al.  Model‐based analysis of multishell diffusion MR data for tractography: How to get over fitting problems , 2012, Magnetic resonance in medicine.

[47]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[48]  Y. Chang,et al.  Human umbilical cord blood–derived mesenchymal stem cell transplantation attenuates severe brain injury by permanent middle cerebral artery occlusion in newborn rats , 2012, Pediatric Research.

[49]  Pierre Gressens,et al.  Microglial Reaction in Axonal Crossroads Is a Hallmark of Noncystic Periventricular White Matter Injury in Very Preterm Infants , 2012, Journal of neuropathology and experimental neurology.

[50]  Steven P. Miller,et al.  Arrested preoligodendrocyte maturation contributes to myelination failure in premature infants , 2012, Annals of neurology.

[51]  Chiara Nosarti,et al.  White Matter and Cognition in Adults Who Were Born Preterm , 2011, PloS one.

[52]  S. Sizonenko,et al.  Systemic inflammation disrupts the developmental program of white matter , 2011, Annals of neurology.

[53]  A. Kavelaars,et al.  Mesenchymal stem cell transplantation changes the gene expression profile of the neonatal ischemic brain , 2011, Brain, Behavior, and Immunity.

[54]  Melissa Brown,et al.  Mechanical Ventilation of the Premature Neonate , 2011, Respiratory Care.

[55]  Hannah C. Kinney,et al.  The developing oligodendrocyte: key cellular target in brain injury in the premature infant , 2011, International Journal of Developmental Neuroscience.

[56]  Riitta Parkkola,et al.  Associations between regional brain volumes at term-equivalent age and development at 2 years of age in preterm children , 2011, Pediatric Radiology.

[57]  Neil Marlow,et al.  Preterm Birth and Childhood Psychiatric Disorders , 2011, Pediatric Research.

[58]  T. Schmitz,et al.  Cellular Changes Underlying Hyperoxia-Induced Delay of White Matter Development , 2011, The Journal of Neuroscience.

[59]  D. Karussis,et al.  Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotection. , 2011, Current stem cell research & therapy.

[60]  Gro C. Christensen Løhaugen,et al.  Young adults born preterm with very low birth weight demonstrate widespread white matter alterations on brain DTI , 2011, NeuroImage.

[61]  A. Kavelaars,et al.  Nasal Administration of Stem Cells: A Promising Novel Route to Treat Neonatal Ischemic Brain Damage , 2010, Pediatric Research.

[62]  W. Deng,et al.  Neurobiology of injury to the developing brain , 2010, Nature Reviews Neurology.

[63]  R. Klein,et al.  CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination , 2010, Proceedings of the National Academy of Sciences.

[64]  J. Pell,et al.  Gestational Age at Delivery and Special Educational Need: Retrospective Cohort Study of 407,503 Schoolchildren , 2010, PLoS medicine.

[65]  W. Deng,et al.  Mouse Models of Periventricular Leukomalacia , 2010, Journal of visualized experiments : JoVE.

[66]  Frank van Bel,et al.  Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration , 2010, Brain, Behavior, and Immunity.

[67]  J. Volpe,et al.  The encephalopathy of prematurity--brain injury and impaired brain development inextricably intertwined. , 2009, Seminars in pediatric neurology.

[68]  Fahmeed Hyder,et al.  Hypoxic injury during neonatal development in murine brain: correlation between in vivo DTI findings and behavioral assessment. , 2009, Cerebral cortex.

[69]  Stefan Skare,et al.  Structural Correlates of Preterm Birth in the Adolescent Brain , 2009, Pediatrics.

[70]  N. Marlow,et al.  Neurodevelopmental Disability Through 11 Years of Age in Children Born Before 26 Weeks of Gestation , 2009, Pediatrics.

[71]  W. Frey,et al.  Intranasal delivery of cells to the brain. , 2009, European journal of cell biology.

[72]  R Todd Constable,et al.  Longitudinal Brain Volume Changes in Preterm and Term Control Subjects During Late Childhood and Adolescence , 2009, Pediatrics.

[73]  J. Volpe.  Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances , 2009, The Lancet Neurology.

[74]  András Vincze,et al.  A correlative light and electron microscopic study of postnatal myelination in the murine corpus callosum , 2008, International Journal of Developmental Neuroscience.

[75]  R. T. Lie,et al.  Long-Term Medical and Social Consequences of Preterm Birth , 2009 .

[76]  G. Breart,et al.  Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study , 2008, The Lancet.

[77]  K. Ligon,et al.  RESEARCH ARTICLE: Myelin Abnormalities without Oligodendrocyte Loss in Periventricular Leukomalacia , 2008, Brain pathology.

[78]  J. Volpe,et al.  Pathogenesis of cerebral white matter injury of prematurity , 2007, Archives of Disease in Childhood Fetal and Neonatal Edition.

[79]  Chiara Nosarti,et al.  Impaired executive functioning in young adults born very preterm , 2007, Journal of the International Neuropsychological Society.

[80]  Jie Peng,et al.  Isolation and culture of rat and mouse oligodendrocyte precursor cells , 2007, Nature Protocols.

[81]  Mark W. Woolrich,et al.  Probabilistic diffusion tractography with multiple fibre orientations: What can we gain? , 2007, NeuroImage.

[82]  M. Höpfner,et al.  Modulation of rat oligodendrocyte precursor cells by the chemokine CXCL12 , 2006, Neuroreport.

[83]  C. Raine,et al.  Human oligodendrocyte precursor cells in vitro: Phenotypic analysis and differential response to growth factors , 2003, Glia.

[84]  Timothy Edward John Behrens,et al.  Characterization and propagation of uncertainty in diffusion‐weighted MR imaging , 2003, Magnetic resonance in medicine.

[85]  H. Kinney,et al.  Nitrosative and Oxidative Injury to Premyelinating Oligodendrocytes in Periventricular Leukomalacia , 2003, Journal of neuropathology and experimental neurology.

[86]  Michael Brady,et al.  Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.

[87]  P. Rezaie,et al.  Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system , 2002, Neuropathology : official journal of the Japanese Society of Neuropathology.

[88]  Chiara Nosarti,et al.  Adolescents who were born very preterm have decreased brain volumes. , 2002, Brain : a journal of neurology.

[89]  Robert Lalonde,et al.  The neurobiological basis of spontaneous alternation , 2002, Neuroscience & Biobehavioral Reviews.

[90]  Stephen M. Smith,et al.  A global optimisation method for robust affine registration of brain images , 2001, Medical Image Anal..

[91]  G. Verellen,et al.  Inflammatory cytokines in the pathogenesis of periventricular leukomalacia , 2001, Neurology.

[92]  Christopher J. Cannistraci,et al.  Regional brain volume abnormalities and long-term cognitive outcome in preterm infants. , 2000, JAMA.

[93]  W. Thomas,et al.  Cellular forms and functions of brain microglia , 1994, Brain Research Bulletin.

[94]  R. Schmidt-Kastner,et al.  Immunohistochemical staining for glial fibrillary acidic protein (GFAP) after deafferentation or ischemic infarction in rat visual system: Features of reactive and damaged astrocytes , 1993, International Journal of Developmental Neuroscience.

[95]  H. Werner,et al.  Insulin-like growth factor I (IGF-I) receptors and IGF-I action in oligodendrocytes from rat brains , 1991, Regulatory Peptides.

[96]  W. Möbius,et al.  Transmission Electron Microscopy of Oligodendrocytes and Myelin. , 2019, Methods in molecular biology.

[97]  M. Benders,et al.  Promoting neuroregeneration after perinatal arterial ischemic stroke: neurotrophic factors and mesenchymal stem cells , 2018, Pediatric Research.

[98]  S. Eustace,et al.  Bone marrow. , 2010, Magnetic resonance imaging clinics of North America.

[99]  Chiara Nosarti,et al.  Grey and white matter distribution in very preterm adolescents mediates neurodevelopmental outcome. , 2008, Brain : a journal of neurology.

[100]  Courtauld,et al.  A Quantitative Method , 2005 .

[101]  J. Birnholz.  Gestational age. , 1984, AJR. American journal of roentgenology.